- Editas Medicine (Cambridge, MA)
- …and more equitable future. Editas Medicine is seeking a highly motivated and collaborative cell biologist to join our In Vivo Therapeutics Discovery group. In ... the power and potential of CRISPR/Cas9 and CRISPR/Cpf1 (Cas12a) gene editing. We believe our people are at the...and characterization of rodent animal models and molecular and cell -based assays to evaluate the extent and effects of… more